ORIGINAL ARTICLE
WHEN SHOULD ONE LOOK FOR IVS1+1G>A SPLICE MUTATION IN PATIENTS WITH NONSYNDROMIC SENSORINEURAL HEARING LOSS?
 
More details
Hide details
1
Institute of Genetics and Cytology, National Academy of Sciences of Belarus, Minsk, Belarus
CORRESPONDING AUTHOR
Olga Shubina-Oleinik   

Olga Shubina-Oleinik, Institute of Genetics and Cytology, National Academy of Sciences of Belarus, Minsk, Belarus, e-mail: oleinik.olga@yahoo.co.uk
Publication date: 2020-04-16
 
J Hear Sci 2014;4(2):24–29
 
KEYWORDS
ABSTRACT
Background:
The splice site nucleotide substitution IVS1+1G>A in the non-coding part of the GJB2 gene is one of the recessive pathogenic mutations causing nonsyndromic sensorineural hearing loss (NSHL). We present here the results of a study of IVS1+1G>A among Belarusian patients with NSHL as well as among Belarusian controls with normal hearing.

Material and Methods:
The PCR-RFLP method was used for genotyping. All tested patients were subdivided into three groups: those who carried only one mutant allele of GJB2 exon 2 (group A, 28 patients), those with no mutation of GJB2 exon 2 (group B, 150 patients), and patients with two mutations previously detected in the second exon of GJB2 or with one mutation and a large GJB6 deletion ∆D13S1830 (group C, 223 patients). Also 300 Belarusian people with normal hearing were screened for IVS1+1G>A.

Results:
We detected 7 patients with IVS1+1G>A mutation in the A group, which explained hearing loss in 25% of this deafness cohort. None of the B or C group patients carried the IVS1+1G>A mutation. We also did not find any IVS1+1G>A mutation carriers among the 300 Belarusian control people with normal hearing.

Conclusions:
IVS1+1G>A is the third-most frequent mutation (after 35delG and 312del14) among Belarusian patients with NSHL; its rate is 1.8% for the patient cohort we studied and the population frequency is below 0.33%. We propose to include the IVS1+1G>A mutation into a laboratory screening protocol for those patients with NSHL that carry one mutant allele of GJB2 exon 2.

FUNDING
The work was supported by a project grant from the Belarusian Republican Foundation for Fundamental Research (BRFFR), project grant Б14Р-081.
 
REFERENCES (25)
1.
Kokotas H, Laer L, Grigoriadou M, Iliadou V, Economides J et al. Strong linkage disequilibrium for the frequent GJB2 35delG mutation in the Greek population. Am J Med Genet, 2008; 146A: 2879–84.
 
2.
Morton C, Nance W. Newborn hearing screening – a silent revolution. N Engl J Med, 2006; 354(20): 2151–64.
 
3.
Pollak A, Skórka A. M34T and V37I mutations in GJB2 associated hearing impairment: evidence for pathogenicity and reduced penetrance. Am J Med Genet, 2007; 143A(21): 2534–43.
 
5.
Snoeckx R, Camp G. Non-syndromic hearing loss: cracking the cochlear code. Nature, 2007; 45: 227–39.
 
6.
Wu C, Hung C, Lin S, Hsieh W, Tsao P et al. Newborn genetic screening for hearing impairment: a preliminary study at a tertiary center. PLoS ONE, 2012; 6(7): e22314.
 
7.
Rodriguez-Paris J, Schrijver I. The digenic hypothesis unraveled: the GJB6 del(GJB6-D13S1830) mutation causes allele-specific loss of GJB2 expression in cis. Biochem Biophys Res Commun, 2009; 389(2): 354–9.
 
8.
Lee J, White T. Connexin-26 mutations in deafness and skin disease. Expert Rev Mol Med, 2009; 11.e35.
 
9.
Zhao H, Kikuchi T, Ngezahayo A, White T. Gap junctions and cochlear homeostasis. J Membrane Biol, 2006; 209(2–3): 177–86.
 
10.
Tekin M, Xia X, Erdenetungalag R, Cengiz FB, White TW, et al. GJB2 mutations in Mongolia: complex alleles, low frequency, and reduced fitness of the deaf. Ann Hum Genet, 2010; 74(2): 155–64.
 
11.
Barashkov N, Dzhemileva L, Fedorova S. Autosomal recessive deafness 1A (DFNB1A) in Yakut population isolate in Eastern Siberia: extensive accumulation of the splice site mutation IVS1+1G>A in GJB2 gene as a result of founder effect. J Hum Genet, 2011; 56(9): 631–9.
 
12.
Hutchin T, Coy N, Conlon H, Telford E. Assessment of the genetic causes of recessive childhood non-syndromic deafness in the UK: implications for genetic testing. Clin Genet, 2005; 68(6): 506–12.
 
13.
Seeman P, Sakmaryova. High prevalence of the IVS1+1G to A/ GJB2 mutation among Czech hearing impaired patients with monoallelic mutation in the coding region of GJB2. Clin Genet, 2006; 69(5): 410–13.
 
14.
Denoyelle F, Marlin S, Marlin S, Weil D et al. Clinical features of the prevalent form of childhood deafness, DFNB1, due to a connexin-26 gene defect: implications for genetic counselling. Lancet, 1999; 353(9161): 1298–303.
 
15.
Green G, Scott, McDonald J. Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. JAMA, 1999; 281(23): 2211–16.
 
16.
Mani R, Ganapathy A, Jalvi R. Functional consequences of novel connexin 26 mutations associated with hereditary hearing loss. Eur J Hum Genet, 2009; 17(4): 502–9.
 
17.
Shahin H, Walsh T, Sobe T, Lynch E, King M et al. Genetics of congenital deafness in the Palestinian population: multiple connexin 26 alleles with shared origins in the Middle East. Hum Genet, 2002; 110(3): 284–89.
 
18.
Bliznetz EA, Galkina AV, Matyushchenko GN, Kisina AG, Markova TG, et al. Changes in the connexin 26 gene (GJB2) in Russian patients with hearing loss: results of long-term molecular diagnostics of hereditary nonsyndromic hearing loss. Genetika, 2012; 48(1): 101–12.
 
19.
Minárik G, Tretinárová D, Szemes T, Kádasi Ľ. Prevalence of DFNB1 mutations in Slovak patients with non-syndromic hearing loss. Int J Pediatric Otorhinolaryngol, 2012; 76(3): 400–3.
 
20.
Sansovic I, Knezevic J, Matijevic T, Balen S. Prevalence of the 35delG mutation in the GJB2 gene of patients with nonsyndromic hearing loss from Croatia. Genet Test, 2005; 9(4): 297–300.
 
21.
Santos RL, Aulchenko YS, Huygen PL, Donk KP, Wijs IJ. Hearing impairment in Dutch patients with connexin 26 (GJB2) and connexin 30 (GJB6) mutations. Int J Pediatric Otorhinolaryngol, 2005; 69(2): 165–74.
 
22.
Tóth T, Kupka S, Haack B. Coincidence of mutations in different connexin genes in Hungarian patients. Int J Mol Med, 2007; 20(3): 315–21.
 
23.
Danilenko N, Merkulava E, Siniauskaya M, Olejnik O. Spectrum of genetic changes in patients with non-syndromic hearing impairment and extremely high carrier frequency of 35delG GJB2 mutation in Belarus. PLoS ONE, 2012; 7(5): e36354.
 
24.
da Silva-Costa SM, Coeli FB, Lincoln-de-Carvalho CR, Marques-de-Faria AP, Kurc M et al. Screening for the GJB2 c.-3170 G>A (IVS1+1G>A) mutation in Brazilian deaf individuals using multiplex ligation-dependent probe amplification. Genet Test, 2009; 13: 701–4.
 
25.
Yuan Y, Yu F, Wang G, Huang S, Yu R et al. Prevalence of the GJB2 IVS1+1G >A mutation in Chinese hearing loss patients with monoallelic pathogenic mutation in the coding region of GJB2. J Transl Med, 2010; 8: 127.